Inaxaplin
id:
inaxaplin-180-4962841
title:
Inaxaplin
text:
Inaxaplin (VX-147) is a small-molecule apolipoprotein L1 inhibitor developed by Vertex Pharmaceuticals for APOL1-mediated kidney disease. In preliminary studies the drug has shown promise in treating people with kidney disease and multiple gain of function mutations on the APOL1 gene.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Inaxaplin
date created:
2023-12-05T02:14:05Z
date modified:
2024-09-05T10:36:53Z
main entity:
{"identifier":"Q123913944","url":"https://www.wikidata.org/entity/Q123913944"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/16/Inaxaplin.svg","width":695,"height":500}
fields total:
13
integrity:
16